- Vaccines for infectious diseases
- Investment Period: 8 years
- IPO, 2005
TVM Capital Managing Partner Helmut Schühsler served on the company board since inception and provided key strategic advice and related contacts that enabled Intercell to grow through the development of both internally developed and in-licensed products. In 2004, the company in-licensed a late-stage product to complement its early-stage pipeline and move closer to the market.